[1] Weldy C S, Syed S A, Amsallem M, et al. Circulating whole genome miRNA expression corresponds to progressive right ventricle enlargement and systolic dysfunction in adults with tetralogy of Fallot[J]. PLoS One, 2020,15(11):e241476.
[2] Mueller A S, McDonald D M, Singh H S, et al. Heart failure in adult congenital heart disease: tetralogy of Fallot[J]. Heart Failure Reviews, 2020,25(4):583-598.
[3] Villafane J, Feinstein J A, Jenkins K J, et al. Hot topics in tetralogy of Fallot[J]. J Am Coll Cardiol, 2013,62(23):2155-2166.
[4] Weng Y, Li C, Yang T, et al. The challenge and prospect of mRNA therapeutics landscape[J]. Biotechnology advances, 2020,40:107534.
[5] Martini P G V, Guey L T. A New Era for Rare Genetic Diseases: Messenger RNA Therapy[J]. Human Gene Therapy, 2019,30(10):1180-1189.
[6] Lei S, Zhang X, Li J, et al. Current Progress in Messenger RNA-Based Gene Therapy[J]. J Biomed Nanotechnol, 2020,16(7):1018-1044.
[7] Preiss D, Mafham M. PCSK9 inhibition: the dawn of a new age in cholesterol lowering?[J]. Diabetologia, 2017,60(3):381-389.
[8] Magadum A, Kaur K, Zangi L. mRNA-Based Protein Replacement Therapy for the Heart[J]. Mol Ther, 2019,27(4):785-793.
[9] Kim D, Langmead B, Salzberg S L. HISAT: a fast spliced aligner with low memory requirements[J]. Nature methods, 2015,12(4):357-360.
[10] Langmead B, Trapnell C, Pop M, et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome[J]. Genome biology, 2009,10(3):R25.
[11] Dewenter M, von der Lieth A, Katus H A, et al. Calcium Signaling and Transcriptional Regulation in Cardiomyocytes[J]. Circulation research, 2017,121(8):1000-1020.
[12] Gilbert G, Demydenko K, Dries E, et al. Calcium Signaling in Cardiomyocyte Function[J]. Cold Spring Harbor perspectives in biology, 2020,12(3):a35428.
[13] Cartwright E J, Mohamed T, Oceandy D, et al. Calcium signaling dysfunction in heart disease[J]. BioFactors (Oxford), 2011,37(3):175-181.
[14] Lin B, Feng D G, Xu J. microRNA‐665 silencing improves cardiac function in rats with heart failure through activation of the cAMP signaling pathway[J]. Journal of cellular physiology, 2019,234(8):13169-13181.
[15] Lohse M J, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?[J]. Circ Res, 2003,93(10):896-906.
[16] Wallukat G. The beta-adrenergic receptors[J]. Herz, 2002,27(7):683-690.
[17] Port J D, Bristow M R. Altered Beta-adrenergic Receptor Gene Regulation and Signaling in Chronic Heart Failure[J]. Journal of molecular and cellular cardiology, 2001,33(5):887-905.
[18] Fujita T, Ishikawa Y. Apoptosis in Heart Failure: The Role of the β-Adrenergic Receptor-Mediated Signaling Pathway and p53-Mediated Signaling Pathway in the Apoptosis of Cardiomyocytes[J]. Circulation journal : official journal of the Japanese Circulation Society, 2011,75(8):1811-1818.
[19] Schumacher-Bass S M, Traynham C J, Koch W J. G protein-coupled receptor kinase 2 as a therapeutic target for heart failure[J]. Drug Discovery Today: Therapeutic Strategies, 2012,9(4):e155-e162.